Inventor · disambiguated record
Fabiola Cecchi
Also filed as: CECCHI FABIOLA
11 granted patents·20 pending applications·11 citations·filing 2013–2019
81Inventor score
Top patents by PatentIndex Score
31 records- 0185US9746477B2Quantifying FR-α and GART proteins for optimal cancer therapyEXPRESSION PATHOLOGY INC·Filed 2016·Granted Aug 29, 2017·11 cites·17 claims
- 0268US11434268B2Vascular endothelial growth factor antagonistsUS HEALTH·Filed 2018·Granted Sep 6, 2022·0 cites·4 claims
- 0365US9550818B2Methods for use of vascular endothelial growth factor antagonistsUS HEALTH·Filed 2013·Granted Jan 24, 2017·0 cites·6 claims
- 0460US10035833B2Vascular endothelial growth factor antagonists and methods of makingUS HEALTH·Filed 2017·Granted Jul 31, 2018·0 cites·14 claims
- 0559US10722509B2Predicting optimal chemotherapy for CRCNANTOMICS LLC·Filed 2019·Granted Jul 28, 2020·0 cites·20 claims
- 0658US10722531B2OPRT expression and cancer treatment outcomeNANTOMICS LLC·Filed 2019·Granted Jul 28, 2020·0 cites·25 claims
- 0758US10725045B2Quantifying MGMT protein for optimal cancer therapy of glioblastomaNANTOMICS LLC·Filed 2019·Granted Jul 28, 2020·0 cites·16 claims
- 0850US10537576B2Methods for treating Her2-positive breast cancerEXPRESSION PATHOLOGY INC·Filed 2016·Granted Jan 21, 2020·0 cites·16 claims
- 0946US10585099B2SRM/MRM assays for cancerEXPRESSION PATHOLOGY INC·Filed 2017·Granted Mar 10, 2020·0 cites·9 claims
- 1046US2019234958A1Detection of Exon 14 Deletion in the Met ProteinNANTOMICS LLC·Filed 2018·Application pending·0 cites
- 1146US2019167628A1Methods for treating sarcomaNANTOMICS LLC·Filed 2018·Application pending·0 cites
- 1243US2020171082A1Quantifying slfn11 protein for optimal cancer therapyNANTOMICS LLC·Filed 2018·Application pending·0 cites
- 1343US2020278353A1Protein Expression Analysis For Breast Cancer Prognosis And TreatmentNANTOMICS LLC·Filed 2018·Application pending·0 cites
- 1443US2019219582A1p16 EXPRESSION AND CANCER TREATMENT OUTCOMENANTOMICS LLC·Filed 2019·Application pending·0 cites
- 1542US10617717B2Methods of treating lung cancer by predicting responders to cisplatin-pemetrexed combination therapyEXPRESSION PATHOLOGY INC·Filed 2017·Granted Apr 14, 2020·0 cites·10 claims
- 1642US2019353660A1Identification of cancer patients sensitive or resistant to 5-fluorouracil (5-fu)NANTOMICS LLC·Filed 2019·Application pending·0 cites
- 1742US2018172690A1Method for improved hepatocellular cancer diagnosisEXPRESSION PATHOLOGY INC·Filed 2017·Application pending·0 cites
- 1842US2019353658A1Improved Methods Of Treating Lung Cancer Using Multiplex Proteomic AnalysisEXPRESSION PATHOLOGY INC·Filed 2017·Application pending·0 cites
- 1941US10288616B2Quantifying met protein for cancer treatmentEXPRESSION PATHOLOGY INC·Filed 2016·Granted May 14, 2019·0 cites·11 claims
- 2041US2020232987A1Proteomic And Genomic Analysis For Colon Cancer PrognosisNANTOMICS LLC·Filed 2018·Application pending·0 cites
- 2141US2020132696A1SRM/MRM Assays For Notch Pathway ProteinsEXPRESSION PATHOLOGY INC·Filed 2019·Application pending·0 cites
- 2241US2020271653A1UCK2 Assay To Predict Cancer Therapy ResponseNANTOMICS LLC·Filed 2018·Application pending·0 cites
- 2341US2019018017A1Integrated Analysis To Determine Prognosis After Treatment For Primary Breast CancerNANTOMICS LLC·Filed 2016·Application pending·0 cites
- 2441US2020103411A1Predicting Cancer Treatment Outcome With T-DM1EXPRESSION PATHOLOGY INC·Filed 2018·Application pending·0 cites
- 2539US2019279771A1SRM/MRM Assays for Profiling Tumor TissueNANTOMICS LLC·Filed 2019·Application pending·0 cites
- 2637US2020271654A1Quantifying MGMT Protein For Optimal Cancer TherapyEXPRESSION PATHOLOGY INC·Filed 2018·Application pending·0 cites
- 2736US2019219549A1SRM/MRM Assay For The Tubulin Beta-3 Chain (TUBB3) ProteinEXPRESSION PATHOLOGY INC·Filed 2017·Application pending·0 cites
- 2835US2020033359A1Immune Profiling Of Tumor TissueEXPRESSION PATHOLOGY INC·Filed 2018·Application pending·0 cites
- 2934US2018180628A1Methods of treating cancer by identification of patients sensitive to fgfr inhibitor therapyEXPRESSION PATHOLOGY INC·Filed 2017·Application pending·0 cites
- 3034US2019285647A1SRM/MRM Assays For CD56 And CHGA ProteinsEXPRESSION PATHOLOGY INC·Filed 2017·Application pending·0 cites
- 3133US2019293652A1Quantifying KRAS for Optimal Cancer TherapyEXPRESSION PATHOLOGY INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fabiola Cecchi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →